APRAMEYA2024-10-012025-03-31APRAMEYA2025-03-31APRAMEYA2024-03-31APRAMEYA2024-04-012025-03-31APRAMEYA2024-10-012025-03-31in-capmkt:OtherExpenses1MemberAPRAMEYA2024-10-012025-03-31in-capmkt:OtherExpenses2MemberAPRAMEYA2024-04-012025-03-31in-capmkt:OtherExpenses1MemberAPRAMEYA2024-04-012025-03-31in-capmkt:OtherExpenses2MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2024-04-012025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2024-04-012025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2024-04-012025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2024-04-012025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2025-03-31in-capmkt:ReportableSegments1MemberAPRAMEYA2024-10-012025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2025-03-31in-capmkt:ReportableSegments2MemberAPRAMEYA2024-10-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1APRAMEYA2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1APRAMEYA2025-03-31Statement1APRAMEYA2024-10-012025-03-31Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares123456APRAMEYANOTLISTEDINE0LQG01010APRAMEYA ENGINEERING LIMITEDSMEEquity2024-04-012025-03-312025-05-082025-05-02INRLakhsHalf YearlyYearlyMulti segment2025-05-0812:30:002025-05-0814:45:00trueCash Flow IndirectNot applicablefalsefalseNANAfalsetrue2022-07-02chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.aelhealth.com/assets/img/policy/Policy-on-Materiality-of-Related-Party-Transactions.pdftrue1falseno default and hence not applicable2024-10-012025-03-31AuditedStandalone126432500031370001267462000045752000-324680001318000020286000486000980099000102733500024012700002401270005750300041990006170200001784250000000178425000-1580001782670001904000001010.2610.260010.2610.26Notes: <BR> <BR> <BR> 1. The above Audited Financial Results have been duly audited by statutory auditors, recommended by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 08th May, 2025 <BR> <BR> 2. Corresponding figures for Half year ended 31.03.2024 are not provided since the company was an unlisted entity during the said period and hence no half yearly results were separately drawn/ reviewed by Board of Directors. <BR> <BR> 3. There are two major Business segments. One is trading of Medical Equipments(Trading Sales) and another is supplies for Infra Projects for health care sectors(Turnkey project supplies). Refer Annexure A Segment Reporting. <BR> <BR> 4. During the year, the company has completed the Initial Public Offer (IPO). pursuant to which 50,40,000 equity shares face value of Rs. 10 each at premium of Rs. 48 per share were allotted . The company got listed on NSE Emerge platform w.e.f. 01.08.2024. <BR> <BR> 5. Pursuant to Section 52 of the Companies Act , 2013 , Securities Premium account has been utilized against share issue expenses related to Issue management fees, brokerage fees ,professional fee and other expenses incurred amounting to Rs. 446.73 lakhs related to the public issue of shares of the company and subsequent listing of the Equity Shares of the company on NSE Emerge platform <BR> <BR> 6. The proceeds from IPO net of expenses is Rs. 2473.44 lakhs and utilisation of the same is provided in the outcome of the Board Meeting. <BR> <BR> <BR> <BR> 7. The figures in respect of results for the half year ended March31, 2025 are the balancing figures between the audited figures in respect of the full financial year and published half yearly figures upto September 30, 2024 <BR> <BR> 8. The Company does not have any subsidary/associate company joint venture and hence consolidated financial statement is not required.2024-04-012025-03-31AuditedStandalone135707100058950001362966000071255000-37804000309540003181300094300010486280001145789000217177000021717700057500000-14870005601300001611640000000161164000-227000160937000190400000104522110009.279.27009.279.27Turnkey Project Expenses899909000Other Expenses80190000Turnkey Project Expenses945222000Other Expenses1034060001263500007730000408000000000462730004627300051890009748000750260007175200001191242000191100012645000025476000123127400006155800013645840000014396100001904000004522110006426110006426110005950900000005950900023820000076700062658000243924000187140003840030004027170001196500065860600053315000208900020331000734341000007969990001439610000Trading Sales62896000Trunkey Project Supply1201429000Trading Sales106670000Trunkey Project Supply12504010001264325000135707100012643250001357071000Trading Sales2042000Trunkey Project Supply336592000Trading Sales11389000Trunkey Project Supply34887400033863400036026300098508000143085000240126000217178000Trading Sales123746000Trunkey Project Supply12310010001354747000848630001439610000Trading Sales73793000Trunkey Project Supply3359350004097280008383700049356500027078000-37804000-6183250000-2557100000-21700003357060000009430000001714000000589500000003011400077180000-284539000-67362000000389910000-10635300000000000020970000004500000000000000000058950000-7410000-406200000247646000000000117050000002174500000108851000-15640000-156400034760001912000Items that will not be reclassified to profit and loss-211000-211000Items that will not be reclassified to profit and loss-304000-304000-53000-7700000-158000-227000Public Issues2024-07-242923200002025-03-31falsefalseNOT APPLICABLENILWe Confirm that there is no deviation and variation in use of proceeds of the fund from the objects as mentioned in offer documentsSaurabh Kishobhai BhattManaging DirectorAhmedabad2025-05-08